Similar articles

• Adjuvant therapy for surgically resected pancreatic adenocarcinoma.

  Abbruzzese JL. Abbruzzese JL. JAMA. 2008 Mar 5;299(9):1066-7. doi: 10.1001/jama.299.9.1066. JAMA. 2008. PMID: 18319419 No abstract available.
• Adjuvant chemotherapy with gemcitabine for patients with resectable pancreatic cancer.

  Maisonneuve P, Lowenfels AB. Maisonneuve P, et al. JAMA. 2007 Jun 20;297(23):2581; author reply 2582. doi: 10.1001/jama.297.23.2581-a. JAMA. 2007. PMID: 17579223 No abstract available.
• Gemcitabine-induced hepatitis in a pancreatic cancer patient receiving adjuvant therapy following metastasectomy.

  Saadati H, Peccerillo J, Kaley K, Schilsky ML, Saif MW. Saadati H, et al. JOP. 2009 Sep 4;10(5):573-5. JOP. 2009. PMID: 19734642 No abstract available.
• [Chemoradiation for pancreatic adenocarcinoma].

  Flandin I, Mornex F, Claude L, Kubas A, Khodri M, Wautot V, Mazeron R, Partensky C. Flandin I, et al. Cancer Radiother. 2004 Nov;8 Suppl 1:S80-7. Cancer Radiother. 2004. PMID: 15679252 Review. French.
• Management of a patient with borderline resectable pancreatic cancer. Case report and review.

  Shah AP, Strauss JB, Leslie WT, Shah A, Mahon B, Abrams RA. Shah AP, et al. Oncology (Williston Park). 2008 Nov 30;22(13):1524-9. Oncology (Williston Park). 2008. PMID: 19133606 Review.